MedTrace Logo

FungiScope - A Global Emerging Fungal Infection Registry

NCT01731353 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-12-05

No results posted yet for this study

Summary

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Conditions

  • Invasive Fungal Disease

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Basilea Pharmaceutica

    collaborator INDUSTRY

  • Cidara Therapeutics Inc.

    collaborator INDUSTRY

  • F2G Biotech GmbH

    collaborator INDUSTRY

  • Matinas Biopharma, Inc

    collaborator INDUSTRY

  • University of Cologne

    lead OTHER

Principal Investigators

  • Oliver A. Cornely, Professor · University Hospital of Cologne

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01731353 on ClinicalTrials.gov